Trade PMCB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
PharmaCyte Biotech, Inc. (PMCB) is trading at US$0.45, down 3.20% today as of Sep 21, 14:47 EDT. The company has a market capitalisation of US$5.72M. Over the past 52 weeks, PMCB has traded between US$0.33 and US$1.51. On Syfe you can trade PMCB with $0 commission and add it to your watchlist.
| Previous close | US$0.46 |
|---|---|
| Market cap | US$5.72M |
| 52-week range | US$0.33 – US$1.51 |
| Volume | 470.78K |
| Exchange | US |
Add to Watchlist
Set Price Alert
PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.
Year: 2003
PharmaCyte Biotech, Inc. (PMCB) stock is trading at US$0.45, -3.20% from the previous close of US$0.46.
The market cap for PharmaCyte Biotech, Inc. (PMCB) stock is approximately US$5.72M.
The 52-week high for PharmaCyte Biotech, Inc. (PMCB) stock is US$1.51.
The 52-week low for PharmaCyte Biotech, Inc. (PMCB) stock is US$0.33.
PharmaCyte Biotech, Inc. (PMCB) does not currently pay a dividend.
Stay on top of PMCB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
